PP
RDY icon

PDS Planning’s Dr. Reddy's Laboratories RDY Stock Holding History

PDS Planning’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$900K Buy
62,103
+7,106
+13% +$95.9K 0.05% 174
2026
Q1 		$762K Buy
54,997
+9,614
+21% +$134K 0.05% 182
2025
Q4 		$637K Buy
45,383
+571
+1% +$8.01K 0.04% 211
2025
Q3 		$626K Sell
44,812
-284
-0.6% -$4.09K 0.04% 203
2025
Q2 		$678K Buy
45,096
+5,681
+14% +$81.1K 0.05% 184
2025
Q1 		$520K Buy
39,415
+7,161
+22% +$98.8K 0.04% 203
2024
Q4 		$509K Sell
32,254
-706
-2% -$10.6K 0.05% 182
2024
Q3 		$524K Sell
32,960
-245
-0.7% -$3.94K 0.05% 188
2024
Q2 		$506K Buy
33,205
+4,785
+17% +$68.6K 0.05% 172
2024
Q1 		$417K Buy
28,420
+2,225
+8% +$32.5K 0.04% 191
2023
Q4 		$365K Buy
26,195
+1,545
+6% +$20.7K 0.04% 198
2023
Q3 		$330K Buy
24,650
+1,560
+7% +$21.1K 0.04% 201
2023
Q2 		$291K Buy
23,090
+545
+2% +$6.36K 0.04% 224
2023
Q1 		$257K Buy
+22,545
New +$243K 0.04% 223

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

PDS Planning's RDY Position: Q2 2026 in Review

PDS Planning increased its Dr. Reddy's Laboratories (RDY) stake by 13% in Q2 2026, buying an estimated $95.9K and bringing the position to 62,103 shares worth $900K. The position accounts for 0.05% of the portfolio, ranked #174.

PDS Planning first reported a position in RDY in Q1 2023 and has held it in 14 quarters since. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • PDS Planning held 62,103 shares of Dr. Reddy's Laboratories worth $900K as of Q2 2026.
  • PDS Planning bought 7,106 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $95.9K.
  • Dr. Reddy's Laboratories made up 0.05% of PDS Planning's portfolio in Q2 2026, its #174 holding.
  • PDS Planning first reported a position in Dr. Reddy's Laboratories in Q1 2023 and has held it in 14 quarters since.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on PDS Planning's 13F filing for Q2 2026, filed 5 Aug 2026.